Purchase Order HHSN302201600110P

Award Date 3/28/16
Potential Completion Date 3/28/16
Potential Value $4.3K
Ultimate Awardee
Macrogen, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
This federal contract award, valued at $118,650.00, was made by the National Institute of Child Health and Human Development to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for sequencing services to support whole exome sequencing research. The award did not have a set-aside designation. Psomagen Inc. is a provider of advanced genomic and molecular biology services to federal agencies, including the National Institutes of Health, U.S. Department of Agriculture, and Smithsonian...
This federal contract award, valued at $9,970.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for the provision of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, to support research initiatives. Psomagen Inc. has established itself as a key provider of genomic services to various federal agencies, particularly within...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a Firm Fixed Price Purchase Order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., for $10,272.00. The contract is for the delivery of 48 units of Whole Exome Sequencing services, with a completion date of February 29, 2020. This contract was not set aside for any specific business size or type. Psomagen Inc. is a multiomics contract laboratory service and...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a subsidiary of Macrogen, Inc. The $5,160.00 firm fixed-price purchase order is for MACROGEN (AMBIS #1555659) and has a period of performance ending on May 18, 2012. There was no set-aside designation for this award. Psomagen Inc. is a provider of genomic sequencing and bioinformatics services. Through this contract, the company likely delivered a range of advanced...
This federal contract award, valued at $4,380.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for a "Human & Herpes Virus mRNA Sequencing Project" in accordance with Psomagen's quote. The contract is a Firm Fixed Price purchase order with an ultimate completion date of August 28, 2014. Psomagen Inc. is not a small business, and the contract did not utilize a set-aside. Macrogen,...
This federal contract, awarded by the National Institute on Aging (a civilian agency of the U.S. government), is for the purchase of whole genome sequencing services from the prime contractor, Psomagen Inc. The contract has a total ceiling value of $7,499,725.00 and is set aside for small businesses. Psomagen Inc. is a subsidiary of Macrogen, Inc. that specializes in providing a range of genomic sequencing, bioinformatics, and related services to federal agencies. Through this contract, Psomagen...

This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $4,250 firm fixed-price purchase order was for unspecified genomic and molecular biology services to support research initiatives at NHGRI. Psomagen Inc. has established itself as a key provider of advanced sequencing and omics capabilities to federal agencies, having been awarded numerous contracts and subcontracts in areas such as neurodegenerative diseases, cancer, infectious diseases, and agricultural genetics. This award was not set aside for small businesses. Macrogen, Inc., through Psomagen, also holds two significant Indefinite Delivery Vehicles (IDVs) - one with the U.S. Department of Agriculture for sequencing services, and a $500 million IDV with the NIH National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative.

Generated 3/26/25, 10:06 AM